Trial Profile
A prospective study of adjunctive use of combined bevacizumab and mitomycin c to trabeculectomy in management of recurrent pediatric glaucoma.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Oct 2016
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Mitomycin
- Indications Glaucoma
- Focus Therapeutic Use
- 16 Oct 2016 New trial record